THE-BANK-OF-LONDON
Anthony Watson, Group Chief Executive and Founder of The Bank of London has been appointed Commander of the Most Excellent Order of the British Empire (CBE) in His Majesty The King’s inaugural Birthday Honours for services to the Lesbian, Gay, Bisexual & Transgender (LGBT) community, for Equality and to Diversity.
Anthony, a veteran of both Wall Street and the City of London and only one of a few people in the world to successfully launch financial disrupters in both the United States and the United Kingdom, has a distinguished career as an entrepreneur, philanthropist, and leading LGBT rights advocate.
The King’s Birthday Honours recognises the achievements and services of people across the United Kingdom and the Commonwealth, and from all walks of life. The CBE is the highest-ranking Order of the British Empire Honours (excluding Knighthood/Damehood) and is senior in order of precedence to the OBE, MBE and BEM.
Harvey Schwartz, Group Chairperson of The Bank of London says: “On behalf of our Board and everyone at our firm, I would like to congratulate Anthony on this tremendous honour, which has been bestowed for his tireless support to the LGBT community. As Britain’s only gay bank CEO, and the first LGBT person in Europe to found a bank, he leads our firm daily with pride, passion and courage.”
Anthony Watson CBE, Group Chief Executive & Founder of The Bank of London, said: “I am quite literally stunned and humbled at being appointed CBE by His Majesty The King for services to the LGBT Community, for Equality and to Diversity. I accept this honour with immense gratitude.”
About The Bank of London
The Bank of London is a principal clearing bank of the United Kingdom and the only mass-commercial sovereign-system reserve bank in the world. The bank prioritises the preservation of depositor’s money and market stability over credit risk or chasing high returns.
As a mass-commercial sovereign-system reserve bank, The Bank of London does not generate credit, liquidity, or investment risk. No depositors’ money is ever loaned, leveraged, or invested. All depositor’s money is held in full and unencumbered at the Central Bank (Bank of England). 100% of depositor’s money is liquid and immediately available upon demand, in-full, en masse.
Who The Bank of London Serves
The bank provides commercial banking solutions for all company and organisation types across most industries, offering:
- Agency, clearing, payment and settlement solutions for regulated and non-regulated domestic and international companies;
- Direct Commercial Banking, serving small and medium businesses as well as corporate, government and institutional clients with an array of account, custody, FX, transaction, and treasury solutions;
- Embedded Banking (As-A-Service), enabling companies to fully embed regulated banking products into their own customer offerings, under their own brand and powered by our bank licence and platform.
The Bank of London, with headquarters in London and offices in New York, Belfast, Charlotte (North Carolina), and Luxembourg, is authorised by the Bank of England’s Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority.
For more information visit: thebankoflondon.com, or on Twitter and Instagram at: @thebankoflondon.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230616050677/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing9.6.2025 07:00:00 CEST | Press release
Azafaros, a clinical-stage biotechnology company developing novel therapies for rare lysosomal storage disorders (LSDs), today announced that it will present at the 2025 BIO International Convention taking place in Boston, USA, from 16-19 June. The company’s presentation is scheduled for Monday, June 16 at 16:45 ET in Room 153B. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses and Niemann-Pick disease type C (NPC). This announcement follows Azafaros’ recently completed and oversubscribed €132 million Series B financing round, which will support advancing nizubaglustat into pivotal clinical development. The company is on track to initiate two Phase 3 trials in GM1/GM2 gangliosidoses and NPC in 2025. Earlier this year, Azafaros reported positive topline results from its ongoing Phase 2 study evaluating n
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release
Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom